HONOLULU — Erythropoietin did not reduce the risk for death or severe disability among infants with hypoxic ischemic encephalopathy already being treated with hypothermia, according to the ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study.

Jelkmann, W. (2013) Physiology and Pharmacology of Erythropoietin. Transfusion Medicine and Hemotherapy, 40, 302-309.

"Differences in oxygen physiology in people with Down syndrome." ScienceDaily. ScienceDaily, 15 August 2024. <www.sciencedaily.com / releases / 2024 / 08 / 240815163614.htm>.

Erythropoietin is a protein that helps the body produce red blood cells. Doctors may test erythropoietin levels in people with anemia or other blood disorders. Learn more about it here.

The global erythropoietin drugs market was valued at USD 10.3 billion in 2022, driven by the increasing prevalence of chronic kidney disease and the increasing incidence of cancer across the globe.

Richter, V., Savery, M.D., Gassmann, M., et al. (2011) Excessive Erythrocytosis Compromises the Blood-Endothelium Interface in Erythropoietin-Overexpressing Mice. The Journal of Physiology, 589, ...

Erythropoietin, or Epo for short, is familiar from doping cases. But the body itself also produces this vital hormone. Now, for the first time, an international research team including UZH ...

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market ...

Jelkmann W(2011) Regulation of erythropoietin production. The Journal of Physiology; 589: 6, 1258-1258. Kalucki SA(2020) Reference values and sex differences in absolute and relative kidney size: a ...

Erythropoietin Drugs Market holds substantial share forecast to 2032, owing to increasing incidence of chronic diseases | insightSLICE The market for Erythropoietin Drugs was valued at US$ 11.1 ...

In a study involving 24 infants with hypoxic–ischemic encephalopathy undergoing therapeutic hypothermia, erythropoietin administered intravenously at a dose of 1000 U per kilogram of body weight ...